Catheters for closing hole in the heart and improved noninvasive blood glucose measuring
This article was originally published in Clinica
Executive Summary
The UK’s R&D sector received a boost last week following an announcement by the government to introduce, from 2013, a scheme to reduce corporation tax from 28% to 10% for patent-derived income. The aim of this so-called Patent Box is to stem the growing tide of drug and technology innovators leaving the UK for kinder tax regimes in the Benelux countries and Switzerland, and to “strengthen incentives to invest in innovative industries”. The scheme only applies to patents granted after new legislation is passed – expected in 2011 – which means the full effects would not be seen for some time. While in the pharmaceutical sector, one of the intended beneficiaries of the scheme, it can take 10 years or more for a new drug to make it to market, and therefore companies will have a long wait before enjoying the lower tax rate. In medtech, where the time between having a patent granted and launching a product is typically much shorter, it is likely to have a more immediate effect.
You may also be interested in...
Report Digest: Discussing What's Going On With Prostate Cancer Diagnosis And Treatment
In this edition of Report Digest, UK-based reporter Barnaby Pickering talks about the prostate cancer diagnostics and minimally invasive treatments markets with analyst Phil Greenfield. The two discuss ongoing developments in both treatment and diagnosis, while exploring driving and limiting factors for both.
Using Digital Tools To Unpick The Adherence Problem
An ambitious five-year public-private partnership plans to tackle non-adherence to medicines by giving patients EU-wide access to regulator-approved digital drug information. One year in, progress has been made in creating an app that could do just this.
In A First, FDA Approves Radioembolization Treatment For Liver Cancer In US
Approval for Boston Scientific’s TheraSphere offers further access to the therapy that, until now, has only been available under a humanitarian device exemption.